Allied Market Research
Loading...
0
Upcoming Allied Market Research
2021
Non-steroidal Anti-inflammatory Drugs (nsaids) Market

Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market by Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, and Others), Route of Administration (Oral and Parenteral), and Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021-2030

A13374
Pages: NA
Nov 2021 | 23 Views
   
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Non-steroidal Anti-inflammatory Drugs (nsaids) Market

Request Now !

Non-steroidal anti-inflammatory drugs are used to treat pain, high fever, and prevention of blood clots. Moreover, when high doses of non-steroidal anti-inflammatory drugs (NSAIDs) are administered, the inflammation is reduced. The non-steroidal drugs having depressing and anti-inflammatory action. Non-steroidal anti-inflammatory drugs (NSAIDs) works by inhibiting the COX-1 and COX-2 enzymes, which are responsible for inflammation. Paracetamol, ibuprofen, aspirin, and naproxen are common types of non-steroidal anti-inflammatory drugs.

Market Scope and Structure Analysis

Report Metric

Details

  Market Size available for years

  2020-2030

  Base year considered

  2020

  Forecast Period

  2021-2030

  Forecast Unit

  Value (USD)

  Segments Covered

Disease Indication, Route of Administration, Distribution Channel and Region

  Regions Covered

North America, Europe, Asia-Pacific and LAMEA

  Companies Covered

Endo, Merck, Depomed, Yunnan Baiyao, Teva, Johnson & Johnson Services, Inc., Allergan, Purdue, Pfizer Inc., GSK plc, Grunenthal, Bayer AG, Sanofi, Eli Lilly, AstraZeneca.

 

 

COVID-19 Impact Analysis

COVID-19 is an infectious disease that first emerged in late December in Hubei province of the Wuhan city in China. The virus that causes, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is highly infectious and is transmitted from person to person. Since the outbreak in December 2019, the disease has spread to across 213 countries around the globe with the World Health Organization declaring it a pandemic on March 11, 2020.

Pharmaceutical and biotech companies along with governments around the globe are working to address the COVID-19 outbreak, from supporting the vaccines development to medicine supply chain planning. Approximately, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a significant increase in demand for the treatment of COVID-19. Such increased demand for these drugs has offered huge opportunities for manufacturers of COVID-19 treatment drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future due to the demand for vaccine and the treatment drugs for COVID-19. This in anticipated to have a significant impact on the non-steroidal anti-Inflammatory drugs (NSAIDs) market.

Top Impacting Factors

  • Rise in chronic pain cases, the surge in inflammation cases, preference of non-steroidal anti-inflammatory drugs (NSAIDs) over the opioids, increase in geriatric population, rise in awareness about the use of non-steroidal anti-inflammatory drugs (NSAIDs) and constant increase in business strategies are factors that drive the growth of the non-steroidal anti-inflammatory drugs (NSAIDs) market.
  • Furthermore, increase in non-steroidal anti-inflammatory drugs (NSAIDs) adoption, advantages and effectiveness using non-steroidal anti-inflammatory drugs (NSAIDs), low cost of treatment, rise in demand for non-steroidal anti-inflammatory drugs (NSAIDs), emerging technology in developing countries, research and development activities, and launch of novel drugs are the key factors that boost the growth of the non-steroidal anti-inflammatory drugs (NSAIDs) market.
  • However, side effects associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs) such as dizziness, nausea, and allergic reactions can limit the growth of the non-steroidal anti-inflammatory drugs (NSAIDs) market.
  • Quick authority approvals by the governments and increase in government initiatives raised awareness and funding in this market are anticipated to provide lucrative opportunities for the expansion of the market.

Market Trend

New R & D Activities to Develop Novel NSAID Products

The U.S. Food and Drug Administration (USFDA) approved over-the-counter diclofenac sodium skin gel 1% of Perrigo Company plc in May 2019. This product provides chronic pain relief.

Teva Pharmaceutical Industries Ltd. announced the launch of Flector 1 Patch in March 2019. The product was released in the U.S. market. It is a non-steroidal anti-inflammatory drug (NSAID) that is used to treat chronic pain caused by minor wounds, injuries, and strains

Key Segment

Segment

Sub-segment

  Disease Indication

  • Arthritis
  • Migraine
  • Ophthalmic Diseases
  • Others

  Route of Administration

  • Oral
  • Parenteral

  Distribution Channel  

  • Hospital Pharmacy
  • Drug Store
  • Retail Pharmacy
  • Online Pharmacy

  Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

 

Key Benefits of the Report

  • This study presents the analytical depiction of Non-steroidal Anti-Inflammatory Drugs (NSAIDs) industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Non-steroidal Anti-Inflammatory Drugs (NSAIDs) market share.
  • The current market is quantitatively analyzed from 2020 to 2028 to highlight the growth scenario of the Non-steroidal Anti-Inflammatory Drugs (NSAIDs) market.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed Non-steroidal Anti-Inflammatory Drugs (NSAIDs) market analysis based on competitive intensity and the that competition will take shape in coming years

Questions answered in the Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Report    

  • Who are the leading market players active in the Non-steroidal Anti-Inflammatory Drugs (NSAIDs) market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the future projections that would help in taking further strategic steps?
  • What is "Non-steroidal Anti-Inflammatory Drugs (NSAIDs)"?
  • What is the prediction of the "Non-steroidal Anti-Inflammatory Drugs (NSAIDs)" Market in the future?
  • Who are the leading global players in the "Non-steroidal Anti-Inflammatory Drugs (NSAIDs)" Market?
  • What are the current and predicted trends?
  • What are the key benefits of the "Non-steroidal Anti-Inflammatory Drugs (NSAIDs)" Market report?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Non-steroidal Anti-inflammatory Drugs (nsaids) Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,995  $8,996
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers